PMID- 36177049 OWN - NLM STAT- MEDLINE DCOM- 20221003 LR - 20221003 IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 13 DP - 2022 TI - Reprogramming alternative macrophage polarization by GATM-mediated endogenous creatine synthesis: A potential target for HDM-induced asthma treatment. PG - 937331 LID - 10.3389/fimmu.2022.937331 [doi] LID - 937331 AB - Cellular energy metabolism plays a crucial role in the regulation of macrophage polarization and in the execution of immune functions. A recent study showed that Slc6a8-mediated creatine uptake from exogenous supplementation modulates macrophage polarization, yet little is known about the role of the de novo creatine de novobiosynthesis pathway in macrophage polarization. Here, we observed that glycine amidinotransferase (GATM), the rate-limiting enzyme for creatine synthesis, was upregulated in alternative (M2) polarized macrophages, and was dependent on the transcriptional factor STAT6, whereas GATM expression was suppressed in the classical polarized (M1) macrophage. Next, we revealed that exogenous creatine supplementation enhanced IL-4-induced M2 polarization, confirming recent work. Furthermore, we revealed that genetic ablation of GATM did not affect expression of M1 marker genes (Nos2, IL1b, IL12b) or the production of nitric oxide in both peritoneal macrophages (PMs) and bone marrow-derived macrophages (BMDMs). By contrast, expression levels of M2 markers (Arg1, Mrc1, Ccl17 and Retnla) were lower following GATM deletion. Moreover, we found that deletion of GATM in resident alveolar macrophages (AMs) significantly blocked M2 polarization but with no obvious effect on the number of cells in knockout mice. Lastly, an upregulation of GATM was found in lung tissue and bronchoalveolar lavage fluid macrophages from HDM-induced asthmatic mice. Our study uncovers a previously uncharacterized role for the de novo creatine biosynthesis enzyme GATM in M2 macrophage polarization, which may be involved in the pathogenesis of related inflammatory diseases such as an T helper 2 (Th2)-associated allergic asthma. CI - Copyright (c) 2022 Yu, Wang, Hu, Ren, Qiu, Li, Zhou, Chen and Chen. FAU - Yu, Li AU - Yu L AD - Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital (Shenzhen People's Hospital) and School of Medicine, Southern University of Science and Technology, Shenzhen, China. FAU - Wang, Lingwei AU - Wang L AD - Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital (Shenzhen People's Hospital) and School of Medicine, Southern University of Science and Technology, Shenzhen, China. FAU - Hu, Guang AU - Hu G AD - Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital (Shenzhen People's Hospital) and School of Medicine, Southern University of Science and Technology, Shenzhen, China. FAU - Ren, Laibin AU - Ren L AD - Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital (Shenzhen People's Hospital) and School of Medicine, Southern University of Science and Technology, Shenzhen, China. FAU - Qiu, Chen AU - Qiu C AD - Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital (Shenzhen People's Hospital) and School of Medicine, Southern University of Science and Technology, Shenzhen, China. FAU - Li, Shun AU - Li S AD - Department of Animal Model, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China. FAU - Zhou, Xiaohui AU - Zhou X AD - Department of Animal Model, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China. FAU - Chen, Shanze AU - Chen S AD - Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital (Shenzhen People's Hospital) and School of Medicine, Southern University of Science and Technology, Shenzhen, China. FAU - Chen, Rongchang AU - Chen R AD - Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital (Shenzhen People's Hospital) and School of Medicine, Southern University of Science and Technology, Shenzhen, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220913 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 RN - 207137-56-2 (Interleukin-4) RN - 31C4KY9ESH (Nitric Oxide) RN - EC 2.1.4.- (Amidinotransferases) RN - EC 2.1.4.1 (glycine amidinotransferase) RN - MU72812GK0 (Creatine) SB - IM MH - Amidinotransferases MH - Animals MH - *Asthma MH - *Creatine/metabolism MH - Interleukin-4/metabolism MH - Macrophages MH - Mice MH - Mice, Knockout MH - Nitric Oxide/metabolism PMC - PMC9513582 OTO - NOTNLM OT - asthma OT - creatine OT - glycine amidinotransferase (GATM) OT - macrophage OT - polarization COIS- The reviewer ZJ declared a shared parent affiliation with the authors, WZ, SL, to the handling editor at the time of the review. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/10/01 06:00 MHDA- 2022/10/04 06:00 PMCR- 2022/01/01 CRDT- 2022/09/30 02:41 PHST- 2022/05/06 00:00 [received] PHST- 2022/08/22 00:00 [accepted] PHST- 2022/09/30 02:41 [entrez] PHST- 2022/10/01 06:00 [pubmed] PHST- 2022/10/04 06:00 [medline] PHST- 2022/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2022.937331 [doi] PST - epublish SO - Front Immunol. 2022 Sep 13;13:937331. doi: 10.3389/fimmu.2022.937331. eCollection 2022.